Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?
e-ESO Podcasts - Een podcast door ESO - European School of Oncology
Categorieën:
Expert: Marwan Tolba, McGill University, Montreal, Canada
